The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2021 Aug 9

PMID 34370287

Citations 82

Authors

Naiara Santana-Codina

Ajami Gikandi

Joseph D Mancias

Affiliations

Soon will be listed here.

Abstract

Nuclear receptor coactivator 4 (NCOA4) is a selective cargo receptor that mediates the autophagic degradation of ferritin, the cytosolic iron storage complex, in a process known as ferritinophagy. NCOA4-mediated ferritinophagy is required to maintain intracellular and systemic iron homeostasis and thereby iron-dependent physiologic processes such as erythropoiesis. Given this role of ferritinophagy in regulating iron homeostasis, modulating NCOA4-mediated ferritinophagic flux alters sensitivity to ferroptosis, a non-apoptotic iron-dependent form of cell death triggered by peroxidation of polyunsaturated fatty acids (PUFAs). A role for ferroptosis has been established in the pathophysiology of cancer and neurodegeneration; however, the importance of ferritinophagy in these pathologies remains largely unknown. Here, we review the available evidence on biochemical regulation of NCOA4-mediated ferritinophagy and its role in modulating sensitivity to innate and induced ferroptosis in neurodegenerative diseases and cancer. Finally, we evaluate the potential of modulating ferritinophagy in combination with ferroptosis inducers as a therapeutic strategy.

Citing Articles

Melatonin alleviates ferroptosis triggered by cadmium via regulating ferritinophagy and iron metabolism in spermatogonia.

Jia D, Huang W, Yin Q, Wang H, Wang Z, Zhang M Sci Rep. 2025; 15(1):8910.

PMID: 40087488 DOI: 10.1038/s41598-025-93822-8.

The Impact of Polyunsaturated Fatty Acids in Cancer and Therapeutic Strategies.

Yan D, Hou Y, Lei X, Xiao H, Zeng Z, Xiong W Curr Nutr Rep. 2025; 14(1):46.

PMID: 40085324 DOI: 10.1007/s13668-025-00639-y.

WBP1 regulates mitochondrial function and ferroptosis to modulate chemoresistance in colorectal cancer.

Wang Y, Qi D, Ge G, Cao N, Liu X, Zhu N Mol Med. 2025; 31(1):93.

PMID: 40075333 PMC: 11900258. DOI: 10.1186/s10020-025-01151-3.

Pulling back the mitochondria's iron curtain.

Ben Zichri-David S, Shkuri L, Ast T NPJ Metab Health Dis. 2025; 3(1):6.

PMID: 40052109 PMC: 11879881. DOI: 10.1038/s44324-024-00045-y.

Ferroptosis and hearing loss: from molecular mechanisms to therapeutic interventions.

Lv X, Yang C, Li X, Liu Y, Yang Y, Jin T J Enzyme Inhib Med Chem. 2025; 40(1):2468853.

PMID: 39992186 PMC: 11852237. DOI: 10.1080/14756366.2025.2468853.

References

Abdalkader M, Lampinen R, Kanninen K, Malm T, Liddell J . Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration. Front Neurosci. 2018; 12:466. PMC: 6048292. DOI: 10.3389/fnins.2018.00466. View

Alen P, Claessens F, Schoenmakers E, Swinnen J, Verhoeven G, ROMBAUTS W . Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol. 1999; 13(1):117-28. DOI: 10.1210/mend.13.1.0214. View

Alvarez S, Sviderskiy V, Terzi E, Papagiannakopoulos T, Moreira A, Adams S . NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017; 551(7682):639-643. PMC: 5808442. DOI: 10.1038/nature24637. View

Asano T, Komatsu M, Yamaguchi-Iwai Y, Ishikawa F, Mizushima N, Iwai K . Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol Cell Biol. 2011; 31(10):2040-52. PMC: 3133360. DOI: 10.1128/MCB.01437-10. View

Atri A . The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. Med Clin North Am. 2019; 103(2):263-293. DOI: 10.1016/j.mcna.2018.10.009. View

Ayton S, Faux N, Bush A . Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat Commun. 2015; 6:6760. PMC: 4479012. DOI: 10.1038/ncomms7760. View

Badgley M, Kremer D, Maurer H, DelGiorno K, Lee H, Purohit V . Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020; 368(6486):85-89. PMC: 7681911. DOI: 10.1126/science.aaw9872. View

Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G . Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene. 2017; 36(29):4089-4099. PMC: 5540148. DOI: 10.1038/onc.2017.11. View

Bates G, Dorsey R, Gusella J, Hayden M, Kay C, Leavitt B . Huntington disease. Nat Rev Dis Primers. 2016; 1:15005. DOI: 10.1038/nrdp.2015.5. View

10.

Bellelli R, Castellone M, Guida T, Limongello R, Dathan N, Merolla F . NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. Mol Cell. 2014; 55(1):123-37. DOI: 10.1016/j.molcel.2014.04.031. View

11.

Bellelli R, Federico G, Matte A, Colecchia D, Iolascon A, Chiariello M . NCOA4 Deficiency Impairs Systemic Iron Homeostasis. Cell Rep. 2016; 14(3):411-421. DOI: 10.1016/j.celrep.2015.12.065. View

12.

Bellinger F, Bellinger M, Seale L, Takemoto A, Raman A, Miki T . Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain. Mol Neurodegener. 2011; 6(1):8. PMC: 3037910. DOI: 10.1186/1750-1326-6-8. View

13.

Bersuker K, Hendricks J, Li Z, Magtanong L, Ford B, Tang P . The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019; 575(7784):688-692. PMC: 6883167. DOI: 10.1038/s41586-019-1705-2. View

14.

Bloom G . Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014; 71(4):505-8. DOI: 10.1001/jamaneurol.2013.5847. View

15.

Bogdan A, Miyazawa M, Hashimoto K, Tsuji Y . Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease. Trends Biochem Sci. 2016; 41(3):274-286. PMC: 4783254. DOI: 10.1016/j.tibs.2015.11.012. View

16.

Brigelius-Flohe R, Maiorino M . Glutathione peroxidases. Biochim Biophys Acta. 2012; 1830(5):3289-303. DOI: 10.1016/j.bbagen.2012.11.020. View

17.

Brown C, Amante J, Chhoy P, Elaimy A, Liu H, Zhu L . Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export. Dev Cell. 2019; 51(5):575-586.e4. PMC: 8316835. DOI: 10.1016/j.devcel.2019.10.007. View

18.

Browne S, Ferrante R, Beal M . Oxidative stress in Huntington's disease. Brain Pathol. 1999; 9(1):147-63. PMC: 8098260. DOI: 10.1111/j.1750-3639.1999.tb00216.x. View

19.

Camaschella C . Iron-deficiency anemia. N Engl J Med. 2015; 372(19):1832-43. DOI: 10.1056/NEJMra1401038. View

20.

Cardoso B, Hare D, Bush A, Roberts B . Glutathione peroxidase 4: a new player in neurodegeneration?. Mol Psychiatry. 2016; 22(3):328-335. DOI: 10.1038/mp.2016.196. View